- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0020014

Aspirer Pharmaceuticals Private Limited
About Aspirer Pharmaceuticals Private Limited
Data last updated:
Aspirer Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2019PTC049471.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Sifti Narang and Mandeep Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 150 – B Basant Vihar Satya Sai, Indore, Madhya Pradesh, India – 452010.
Aspirer Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0020014).
Company details
Recognitions & Rankings of Aspirer Pharmaceuticals
Contact details
Aspirer Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address150 – B Basant Vihar Satya Sai, Indore, Madhya Pradesh, India – 452010
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aspirer Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aspirer Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aspirer Pharmaceuticals Private Limited
Aspirer Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sifti Narang | Director | 29 Aug 2019 | 7 Years 2 Months | Current |
| Mandeep Kaur Also directs: Mobirx Private Limited | Director | 29 Aug 2019 | 7 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Aspirer Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspirer Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aspirer Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aspirer Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Mandeep Kaur was appointed as Director on 29 Aug 2019.
Frequently asked questions
Aspirer Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 August 2019 (7+ years old) and is registered under CIN U24230MP2019PTC049471.
Aspirer Pharmaceuticals has 2 current directors:
- Sifti Narang - Director
- Mandeep Kaur - Director
The latest financial statements of Aspirer Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Aspirer Pharmaceuticals is U24230MP2019PTC049471. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspirer Pharmaceuticals was incorporated on 29 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
Mandeep Kaur was appointed as Director on 29 Aug 2019. Sifti Narang was appointed as Director on 29 Aug 2019.
Yes, Aspirer Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0020014).
The registered office of Aspirer Pharmaceuticals is at 150 – B Basant Vihar Satya Sai, Indore, Madhya Pradesh, India – 452010.
Aspirer Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Aspirer Pharmaceuticals can be reached at its registered office: 150 – B Basant Vihar Satya Sai, Indore, Madhya Pradesh, India – 452010.

